IRIS Accounts Production v23.3.1.45 10227718 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary Share 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh102277182022-03-31102277182023-03-31102277182022-04-012023-03-31102277182021-03-31102277182021-04-012022-03-31102277182022-03-3110227718ns10:Originalns15:EnglandWales2022-04-012023-03-3110227718ns14:PoundSterlingns10:Original2022-04-012023-03-3110227718ns10:Originalns10:Director12022-04-012023-03-3110227718ns10:Original2022-04-012023-03-3110227718ns10:Original2023-03-3110227718ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3110227718ns10:Originalns10:SmallEntities2022-04-012023-03-3110227718ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3110227718ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3110227718ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3110227718ns10:Originalns10:FullAccounts2022-04-012023-03-3110227718ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3110227718ns10:Originalns10:Director22022-04-012023-03-3110227718ns10:Originalns10:RegisteredOffice2022-04-012023-03-3110227718ns10:Original2022-03-3110227718ns10:Originalns5:CurrentFinancialInstruments2023-03-3110227718ns10:Originalns5:CurrentFinancialInstruments2022-03-3110227718ns10:Originalns5:Non-currentFinancialInstruments2023-03-3110227718ns10:Originalns5:Non-currentFinancialInstruments2022-03-3110227718ns5:ShareCapitalns10:Original2023-03-3110227718ns5:ShareCapitalns10:Original2022-03-3110227718ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3110227718ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3110227718ns10:Original2021-04-012022-03-3110227718ns10:Originalns5:PlantMachinery2022-03-3110227718ns10:Originalns5:FurnitureFittings2022-03-3110227718ns10:Original2022-03-3110227718ns10:Originalns5:PlantMachinery2022-04-012023-03-3110227718ns10:Originalns5:FurnitureFittings2022-04-012023-03-3110227718ns10:Originalns5:PlantMachinery2023-03-3110227718ns10:Originalns5:FurnitureFittings2023-03-3110227718ns10:Originalns5:PlantMachinery2022-03-3110227718ns10:Originalns5:FurnitureFittings2022-03-3110227718ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3110227718ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3110227718ns10:Originalns10:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: 10227718 (England and Wales)










Kinsella Aesthetics Ltd

Unaudited Financial Statements

for the Year Ended 31 March 2023






Kinsella Aesthetics Ltd (Registered number: 10227718)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Kinsella Aesthetics Ltd

Company Information
for the Year Ended 31 March 2023







DIRECTORS: Mr Edward Kinsella
Dr Martin James Kinsella





REGISTERED OFFICE: 31 Sackville Street
Manchester
England
M1 3LZ





REGISTERED NUMBER: 10227718 (England and Wales)





ACCOUNTANTS: SKS Shacter Cohen & Bor Ltd
Chartered Accountants
31 Sackville Street
Manchester
M1 3LZ

Kinsella Aesthetics Ltd (Registered number: 10227718)

Balance Sheet
31 March 2023

2023 2022
Notes £    £   
FIXED ASSETS
Tangible assets 5 49,106 39,600

CURRENT ASSETS
Debtors 6 241,906 229,508
Cash at bank 8,381 59,893
250,287 289,401
CREDITORS
Amounts falling due within one year 7 (249,611 ) (250,859 )
NET CURRENT ASSETS 676 38,542
TOTAL ASSETS LESS CURRENT
LIABILITIES

49,782

78,142

CREDITORS
Amounts falling due after more than one year 8 (49,095 ) (69,250 )
NET ASSETS 687 8,892

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 587 8,792
SHAREHOLDERS' FUNDS 687 8,892

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Kinsella Aesthetics Ltd (Registered number: 10227718)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 February 2024 and were signed on its behalf by:





Dr Martin James Kinsella - Director


Kinsella Aesthetics Ltd (Registered number: 10227718)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. GENERAL INFORMATION

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
31 Sackville Street
Manchester
M1 3LZ
England

The principal place of business is:
Progress House
17 Cecil Road
Hale
Cheshire
WAI5 9NZ

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

3. ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND KEY ACCOUNTING ESTIMATES
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

BASIS OF PREPARATION
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

REVENUE RECOGNITION
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company's activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

TAX
The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

TANGIBLE ASSETS
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Kinsella Aesthetics Ltd (Registered number: 10227718)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

DEPRECIATION
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class Depreciation method and rate
Plant and machinery 20% Reducing Balance
Fixtures and fittings 20% Reducing Balance

CASH AND CASH EQUIVALENTS
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

TRADE DEBTORS
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

TRADE CREDITORS
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

BORROWINGS
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

LEASES
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Kinsella Aesthetics Ltd (Registered number: 10227718)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

SHARE CAPITAL
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

DIVIDENDS
Dividend distribution to the company's shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

DEFINED CONTRIBUTION PENSION OBLIGATION
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and
machinery fittings Totals
£    £    £   
COST
At 1 April 2022 49,500 - 49,500
Additions 17,700 3,258 20,958
At 31 March 2023 67,200 3,258 70,458
DEPRECIATION
At 1 April 2022 9,900 - 9,900
Charge for year 11,018 434 11,452
At 31 March 2023 20,918 434 21,352
NET BOOK VALUE
At 31 March 2023 46,282 2,824 49,106
At 31 March 2022 39,600 - 39,600

Kinsella Aesthetics Ltd (Registered number: 10227718)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Amounts owed by associates 219,792 159,509
Other debtors 22,114 69,999
241,906 229,508

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 10,648 -
Hire purchase contracts 10,061 16,500
Trade creditors 20,563 (374 )
Amounts owed to associates 178,800 211,800
Taxation and social security 27,353 22,933
Other creditors 2,186 -
249,611 250,859

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans 29,845 50,000
Hire purchase contracts 19,250 19,250
49,095 69,250

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary Share 1 100 100

10. DIVIDENDS

Final dividends paid
2023(£) 2022(£)
Final dividend of £570.00 (2022 - £1,500.00) per each Ordinary share 57,000 115,000

11. PARENT AND ULTIMATE PARENT UNDERTAKING

The company's immediate parent is Kinsella Holdings Limited, incorporated in England and Wales.

The ultimate controlling party is Dr Martin James Kinsella.